Literature DB >> 16332624

DNA adduct formation by ochratoxin A: review of the available evidence.

Angela Mally1, Wolfgang Dekant.   

Abstract

The mycotoxin ochratoxin A (OTA) is a potent nephrotoxin and renal carcinogen in rodents. However, the mechanism of OTA-induced tumour formation is unknown and conflicting results regarding the potential of OTA to react with DNA have been obtained. While experiments using radiolabelled ((3)H or (14)C) OTA and liquid scintillation counting or accelerator mass spectrometry indicate lack of formation of covalent DNA-adducts, spots detected by (32)P-postlabelling have been attributed to treatment with OTA. However, these putative DNA-adducts have not been shown to contain OTA or part of the OTA molecule and so far no structural information has been provided. Consistent with the absence of DNA-binding of radiolabelled OTA, studies on biotransformation in vivo and in vitro indicate that OTA is poorly metabolized and does not form reactive intermediates capable of interacting with DNA. Recently however, the structures of a carbon- and an oxygen-bonded OTA-deoxyguanosine adduct which is formed by photoirradiation of OTA in the presence of deoxyguanosine have been reported and suggested to be involved in OTA carcinogenicity. The aim of this manuscript is to provide an overview of the available literature regarding DNA adduct formation by OTA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16332624     DOI: 10.1080/02652030500317544

Source DB:  PubMed          Journal:  Food Addit Contam        ISSN: 0265-203X


  9 in total

Review 1.  Accelerator mass spectrometry-enabled studies: current status and future prospects.

Authors:  Ali Arjomand
Journal:  Bioanalysis       Date:  2010-03       Impact factor: 2.681

2.  Comparison of ochratoxin A levels in edible pig tissues and in biological fluids after exposure to a contaminated diet.

Authors:  Jelka Pleadin; Nina Kudumija; Dragan Kovačević; Giampiero Scortichini; Salvatore Milone; Ivana Kmetič
Journal:  Mycotoxin Res       Date:  2016-04-08       Impact factor: 3.833

3.  Perturbation of mitosis through inhibition of histone acetyltransferases: the key to ochratoxin a toxicity and carcinogenicity?

Authors:  Kristin Czakai; Katja Müller; Pasquale Mosesso; Gaetano Pepe; Markus Schulze; Antje Gohla; Debasis Patnaik; Wolfgang Dekant; Jonathan M G Higgins; Angela Mally
Journal:  Toxicol Sci       Date:  2011-05-06       Impact factor: 4.849

4.  Ochratoxin A in human blood serum - retrospective long-term data.

Authors:  Erwin Märtlbauer; Ewald Usleber; Richard Dietrich; Elisabeth Schneider
Journal:  Mycotoxin Res       Date:  2009-09-15       Impact factor: 3.833

Review 5.  Role of exposure analysis in solving the mystery of Balkan endemic nephropathy.

Authors:  David T Long; Thomas C Voice
Journal:  Croat Med J       Date:  2007-06       Impact factor: 1.351

Review 6.  Ochratoxin A in Moroccan foods: occurrence and legislation.

Authors:  Abdellah Zinedine
Journal:  Toxins (Basel)       Date:  2010-05-14       Impact factor: 4.546

Review 7.  Balkan endemic nephropathy: an update on its aetiology.

Authors:  Marie Stiborová; Volker M Arlt; Heinz H Schmeiser
Journal:  Arch Toxicol       Date:  2016-08-19       Impact factor: 5.153

Review 8.  Comparative Ochratoxin Toxicity: A Review of the Available Data.

Authors:  Alexandra H Heussner; Lewis E H Bingle
Journal:  Toxins (Basel)       Date:  2015-10-22       Impact factor: 4.546

9.  Maternal-Fetal Cancer Risk Assessment of Ochratoxin A during Pregnancy.

Authors:  Chit Shing Jackson Woo; Hani El-Nezami
Journal:  Toxins (Basel)       Date:  2016-03-23       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.